The Effects of Intravitreal Ozurdex Implant in DME
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Intravitreal Ozurdex implant therapy improves visual outcome and OCT findings. The purpose of
this study is that these results are correlated with the change of cytokine level known to be
increased in DME patients.